C-Mer Eye Care Holdings (HKSE:03309) 3-Year Revenue Growth Rate : 34.20% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings 3-Year Revenue Growth Rate?

C-Mer Eye Care Holdings's Revenue per Share for the six months ended in Dec. 2023 was HK$0.78.

During the past 12 months, C-Mer Eye Care Holdings's average Revenue per Share Growth Rate was 9.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 34.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 32.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 10 years, the highest 3-Year average Revenue per Share Growth Rate of C-Mer Eye Care Holdings was 37.70% per year. The lowest was 25.90% per year. And the median was 29.30% per year.

Competitive Comparison of C-Mer Eye Care Holdings's 3-Year Revenue Growth Rate

For the Medical Care Facilities subindustry, C-Mer Eye Care Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C-Mer Eye Care Holdings's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, C-Mer Eye Care Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where C-Mer Eye Care Holdings's 3-Year Revenue Growth Rate falls into.

C-Mer Eye Care Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

C-Mer Eye Care Holdings (HKSE:03309) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

C-Mer Eye Care Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of C-Mer Eye Care Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

C-Mer Eye Care Holdings (HKSE:03309) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG

Website

https://www.cmereye.com

C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.

Executives

C-mer Group Limited	2101 Beneficial owner
Lam Shun Chiu Dennis	2201 Interest of corporation controlled by you
Li Xiaoting	2201 Interest of corporation controlled by you

C-Mer Eye Care Holdings (HKSE:03309) Headlines

No Headlines